As Gain Therapeutics announces positive Phase 1b results for its lead compound, GT-02287, pharmaphorum looks back to a ...

In theory, a reference range should be a universal physiological constant that applies to humans regardless of where or how ...

The regulatory authorities in the UK and US have agreed to work more closely together on the regulation of medical ...

In drug development, that means showing how models are trained, which data are used, and how predictions of safety and ...

Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis ...

The UK government is considering ways to raise the price of medicines used by the NHS in an attempt to prevent further ...

The vending machines will start to roll out in Los Angeles in December and carry a range of drugs like antibiotics, asthma ...

Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for adults ...

The executives at this VIP roundtable were encouraged to share their thoughts on how AI innovation has been accelerating in ...

The former director of the FDA's Center for Biologics Evaluation and Research (CBER), Peter Marks, has joined Eli Lilly as ...

Speculation is building that President Donald Trump may delay the introduction of his 100% tariff rate on pharmaceutical imports in order to negotiate more deals with drugmakers on drug pricing. The ...

The green light for Evita Solutions' generic has stoked fury among anti-abortion groups, including the Family Research ...